Shilpa Medicare is managed by a well experienced group of leaders who share the passion and zeal to achieve Shilpa Medicare’s vision of “Innovating for Affordable Healthcare” ®. With their vast expertise in diverse sectors of pharma business, our team brings on board care, creativity, enthusiasm and commitment for achieving ‘Affordable Healthcare’ for everyone. Our team creates value to our customers, shareholders, partners and providing care for employees at all levels in the organization.
Mr. Omprakash Innani has more than 30 years of business experience. Adroit and adept, he monitors business and functional aspects of the Company along with the operations of all the plants. Additionally, he is also member of Audit and Remuneration committee of the Group. In the public domain also he graces several offices. He is a Council Member in the “Academy of Medical Education, Dental College & V.L. College of Pharmacy”, “Taranath Shikshana Samsthe, Raichur” and a trustee in “Akhil Bhartiya Maheshwari Education Trust, Pune” and Managing Committee Member of “Karnataka State Cotton Association, Hubli”.
Mr. Vishnukant is an indefatigable person and has vast business experience of APIs and Intermediates and presently leads the core business and functional teams of Shilpa which accelerate growth and performance by “Innovating for Affordable solutions”. He is the key strategy decision maker for successful API and Generics formulation. His determined efforts have led the company to a leading position in the Indian pharmaceutical domain and helped create a prominent presence for Oncology APIs globally. For his untiring efforts, Mr. Vishnukant was awarded “Best Entrepreneur Award” by Late Dr Shankar Dayal Sharma – the then President of India, in 1995. Other state honors conferred upon him were “Best Entrepreneur” from the Karnataka State Govt. in 1996; “Excellence in Exports” from Vishweshwarayya Industrial Trade Centre, Bangalore in 1996; and Export Excellence Award-2006” by FKCCI, Bangalore. Success seemed to be his second nature, for awards that kept following him like “First Runner Up” at the Emerging India Awards 2008 by CNBC TV18 at London and the “Best National Energy Conservation Award in Drugs & Pharmaceutical Sector for the year 2012” for energy sustainability in the Shilpa group by the then President of India, Dr. Pranab Mukherjee.
Mr. Alpesh Dalal is a qualified Chartered Accountant with around 23 years of experience in diverse finance functions of corporate finance, business partnering, M&A, strategy, fund raising, controllership and investor relations. Additionally, he has cleared Registered Valuer examination for Securities or Financial Assets Class conducted by IBBI
Being a commercially astute professional, Mr. Dalal has successfully concluded 20+ M&A, fund raising, corporate restructuring & JV restructuring deals and has also worked on new business development initiatives & cost rationalisation measures during his career. He brings to table rich experience of having worked with large pharma companies like Lupin Ltd, Cipla Ltd and Wockhardt Ltd apart from diverse industry exposure with Thomas Cook (I) Ltd and Raymond Ltd.
Dr Jayant Karajgi is a pharmacist by education and training. He holds Master’s and Doctorate degrees in Pharmaceutical Technology and is a University Gold Medallist for Bachelor’s and Master’s degrees.
He comes to Shilpa with 27 years of experience in generic pharmaceutical industry out of which last 13 years have been at leadership level as a techno-commercial professional, leading his teams to achieve business goals. His experience spans across all types of finished dosage forms and related operational aspects like product development, analytical and quality control laboratory, compliance, technology transfer, manufacturing, regulatory, customer management and supply chain. He has many international publications and patents to his credit and is an invited speaker across industry conferences and academic institutions.
He has developed and launched more than 400 products across various dosage forms for sale in US, EU, Japan and major ROW markets.
Mr. Prakash is an MMS - Marketing from NMIMS and BE Chemical Engineering from Mumbai University having 29 years of experience in the API industry.
Prakash has led the Sales and Marketing functions of API business in several leading companies and has successfully formulated business strategies for sustainable growth. Building a balanced API portfolio backed by marketing plans across geographies and analyzing key business drivers to achieve sales and profitability growth have been his achievements.
Establishing new and managing ongoing alliances and partnerships with global generic companies and thereby effectively managing customer relationship is his forte.
Mr. K H Honneshaiah is Head Operation of API at Shilpa Medicare Ltd. He holds the Master degree graduate (M. Sc.) with 30 years of API experience, worked with difference capacity in reputed organization like General Manager & Vice President.
He is having experience of Production, Technology transfer, Process development & other service department like Engineering & project.
Also having experience of different business initiatives like Six sigma, lean Management & TPM which adds value to the business drive.
Successfully head many regulatory audits.
Dr. Seshachalam by qualification holds M.Sc (Chemistry) and Ph.D. (Chemistry) and joined Shilpa Medicare in 2008. He is presently heading Quality and Regulatory Affairs departments of Shilpa's API division. He has vast experience of handling of Regulatory audits and DMF submissions with global regulatory agencies.
Being instrumental in Shilpa Medicare's efforts to achieve recognition of different authorities, his key contribution in successful inspection and audit by various regulatory authorities is one of the core strength to the organization's aims and objectives.
Mr. R. K. Somani is a professional Chartered Accountant and also holds a Diploma in Central Excise Laws. He has overall business experience of 21 years plus predominantly in the field of pharmaceuticals and brings to fore key insights and perspectives.
One of the key drivers of Formulation business besides various key Contract Businesses of advanced oncology/ non-Oncology APIs, Mr Somani is known for successfully building formulations portfolio and orchestrating the Generic sales operation.
Mr Seshu Akula is a seasoned pharmaceutical industry professional with 32+ years Senior Level leadership experience. Seshu worked in various leadership positions with responsibilities including PnL Management, New Business Creation, Portfolio Strategy, Business Planning and Operational strategy, Corporate business development. His deep understanding of various business verticals including the API’s , Finished Dosages, Disease categories, Brand marketing, IP Landscape, Portfolio Strategy & product selection, Development and regulatory nuances with established front-end sales and commercial skills lead to several success stories in the industry. Seshu’s last 21 years are based in the US and his previous 11 years in the Indian and other Global markets
Seshu hold an undergrduate degree in B Pharmacy ( Hons) from BITS-Pilani and an M.B.A from the TAPMI Management School
Dr Ganesh is having 22 years of reach Research experience in Pharmaceutical R & D. He is technically-inclined and highly analytical professional having worked with eminent organizations including FTF Pharma Pvt Ltd (Group companies of Shilpa Medicare), Par Pharma (Endo), Ferring Pharma, Getz Pharma Research, Inventia Healthcare (Themis), Tokyo University (Japan) and Dr. Reddy's Lab. He has completed his Ph D (Tech) from Institute of Chemical Technology (Formerly UDCT) with Gold Medal and Post-doctoral research from Tokyo University of Science, Japan. He is proficient leader with extensive expertise and passion for delivering complex products in OSD, Injectables, Ophthalmic and Transdermal DDS including Nanotech DDS. He has filed 200+ ANDAs (ANDA for US, Dossier for EU) for OSD (ER , CR, MR Tablets & capsules, Trilayer/ Bilayer CR Tablets), Sterile dosage forms like simple, complex injections, Ophthalmic, Transdermal etc., Oral peptide / macromolecules delivery, Bio enhancement with New Technologies like Nanoemulsions, Nanoparticles, SMEDDS, Lyophilised ODTs etc. He has excellent expertise on FTF and 505 B2 applications. He has filed more than 30 patents on Innovation and new technologies in drug delivery systems, published 15 research papers in eminent journals, presented > 25 research articles in various national and international conferences and delivered several seminars in various forums. He has worked in various R & D s including Denmark & Japan. He has demonstrated success in setting-up Global Formulation Development laboratories and US FDA approved plants in several organizations with record time.